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Summary
Nicotinic acetylcholine receptors (nAChRs) affect
a wide array of biological processes, including learn-
ing and memory, attention, and addiction. lynx1, the
founding member of a family of mammalian prototox-
ins, modulates nAChR function in vitro by altering ag-
onist sensitivity and desensitization kinetics. Here we
demonstrate, through the generation of lynx1 null
mutant mice, that lynx1 modulates nAChR signaling
in vivo. Its loss decreases the EC50 for nicotine by
w10-fold, decreases receptor desensitization, ele-
vates intracellular calcium levels in response to nico-
tine, and enhances synaptic efficacy. lynx1 null mu-
tant mice exhibit enhanced performance in specific
tests of learning and memory. Consistent with reports
that mutations resulting in hyperactivation of nAChRs
can lead to neurodegeneration, aging lynx1 null mu-
tant mice exhibit a vacuolating degeneration that is
exacerbated by nicotine and ameliorated by null muta-
tions in nAChRs. We conclude that lynx1 functions as
an allosteric modulator of nAChR function in vivo, bal-
ancing neuronal activity and survival in the CNS.
Introduction
Nicotinic acetylcholine receptors (nAChRs) make up
a family of ionotropic, ligand-gated ion channels, which
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Connecticut 06519.contribute to a wide range of functions in the central ner-
vous system, including learning and memory, locomo-
tion, and attention (reviewed in Rezvani and Levin,
2001; Picciotto et al., 2000). nAChRs are gated by the
neurotransmitter (NT) acetylcholine (ACh), which is re-
leased from axonal terminals distributed throughout
the brain, as well as by the drug nicotine, which is the
primary addictive agent in tobacco (US Department of
Health and Human Services, 1988). Activation of post-
synaptic nAChRs induces depolarizing inward currents
that typically increase firing frequencies, whereas acti-
vation of nAChRs located on presynaptic terminals con-
tributes to Ca2+ flux into the terminal augmenting NT
release (reviewed in Dani, 2001). Activation of nAChRs
can thus shift the balance of competing inhibitory and
excitatory inputs toward excitation, producing synaptic
changes that can facilitate learning and memory (Mann
and Greenfield, 2003, Mansvelder and McGehee, 2000).
The importance of maintaining the proper balance of
cholinergic signaling has been well documented. For ex-
ample, reductions in nAChR levels or activity have been
correlated with Alzheimer’s disease, schizophrenia, Par-
kinson’s disease, and dementia (Picciotto and Zoli,
2002; Lindstrom, 1997), and mice lacking nAChR sub-
units exhibit enhanced neurodegeneration (Zoli et al.,
1999). Under some circumstances, nAChR activation
can play a neuroprotective role, reducing the cell’s sen-
sitivity to excitotoxicity, while in other cases, overactiva-
tion of nAChRs can be detrimental. For instance, high
doses of nicotine can induce epilepsy (Damaj et al.,
1999) and cause cell death (Abrous et al., 2002), and
knockin mice with hyperactive a7 or a4 nAChRs exhibit
lower seizure thresholds (Fonck et al., 2003, 2005;
Broide et al., 2002) and suffer from neuronal loss (Orb
et al., 2004; Labarca et al., 2001; Orr-Urtreger et al.,
2000). Even subtle alterations in nAChR activity, such
as those resulting from changes in desensitization kinet-
ics, can have important consequences on cholinergic
function (Dani et al., 2000; Wooltorton et al., 2003).
One form of epilepsy, ADNFLE, caused by mutations in
the widely expressed nAChR subunits a4 or b2, results
from altered desensitization and gating properties of
nAChRs (Bertrand et al., 1998; Kuryatov, et al., 1997).
Taken together, these studies highlight the importance
of cholinergic tone in normal CNS function and illustrate
the detrimental effects that chronic hyperactivation of
nAChRs can have on neurons and neuronal ensembles
in vivo.
We have previously reported the identification of a
cholinergic modulator, lynx1 (Miwa et al., 1999), which
can form stable associations with nAChRs and alter their
function in vitro (Ibanez-Tallon et al., 2002). lynx1, an
evolutionary precursor to snake venom toxins, shares
structural characteristics with toxins such as a- and k-
bungarotoxins, which bind tightly to nAChRs and inhibit
their activation. When coexpressed with lynx1, a4b2
nAChRs are less sensitive to ACh, display more rapid
desensitization, and recover more slowly from desen-
sitization. Single-channel studies of a4b2 receptors
indicate that lynx1 shifts the distribution of channel
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588Figure 1. Generation of lynx1 Null Mutations
through Targeted Mutagenesis
(A) Targeting strategy to remove the lynx1
gene using homologous recombination. The
upper diagram represents a large region of
genomic DNA surrounding the lynx1 gene, in-
cluding its four exons (blue boxes) spanning
6 kb. The targeting construct (middle) repre-
sents a 9 kb HindIII (H) lynx1 genomic frag-
ment, with the neo gene (green) inserted after
the second exon of the lynx1 gene. The
bottom part of the drawing represents the
modified lynx1 gene after recombination.
(B) Genomic Southern analysis of lynx1 null
mutant mouse genomic DNA demonstrates
loss of the lynx1 coding sequence. The mu-
tant SSP1 band is 12 kb (upper arrow), and
the wt band is 9 kb (lower arrow).
(C) Western blot analysis demonstrates a loss
of the lynx1 protein in lynx12/2 brain extracts.openings toward a faster inactivating species with more
uniform, larger amplitude currents. These data, along
with studies showing that lynx1 colocalizes and coim-
munoprecipitates with a7 and b2 nAChR subunits, are
strong indicators that lynx1 has a critical role in modulat-
ing cholinergic activity in vivo.
To test the hypothesis that lynx1 serves as an endog-
enous regulator of nAChR activity in vivo, we generated
a targeted deletion of the lynx1 gene in mice using
homologous recombination. Because lynx1 both de-
creases nAChR sensitivity and increases desensitiza-
tion, we postulated that its removal would reduce
nAChR desensitization and increase ligand sensitivity,
a condition that could lead to novel insights into cholin-
ergic function. We report here that neurons from lynx1
null mutant brains demonstrate heightened sensitivity
to nicotine, and a corresponding increase in Ca2+ levels
in response to nicotine treatment. In addition, lynx1 null
mutant animals display enhanced learning and memory
in a fear-conditioning paradigm and show a correlated
reduction in paired-pulse facilitation (PPF). They also
display an increased sensitivity to nicotine in the ro-
tarod test of motor learning. These data support the
hypotheses that lynx1 normally decreases activity of
nAChRs and, thus, deletion of lynx1 shifts the balance
in favor of increased neuronal activity and synaptic
plasticity.
Our studies also reveal that the short-term benefits of
the loss of lynx1 are counterbalanced by an increased
vulnerability of lynx1 mutant neurons to glutamate toxic-
ity and by loss of nicotine’s neuroprotective effect on
these cells. Consistent with these findings, lynx1 mutant
mice exhibit age-dependent degeneration that is exac-
erbated by nicotine and rescued by null mutations in
nAChR subunits. These data are consistent with previ-
ous studies demonstrating the neurotoxic effects of
mutant hypersensitive variants of nAChRs in vivo. Taken
together, our data demonstrate that lynx1 modulates
nAChR function in vivo and that it plays a critical role
in maintaining a balance between the beneficial effects
of short-term nAChR activation and the potentiallydevastating degenerative effects of chronic activation
of these critical CNS receptors.
Results
Generation of lynx1 Null Mutant Mice
We generated a deletion of the lynx1 coding sequence
through gene targeting in mice using homologous re-
combination in ES cells (Figure 1A). The targeting con-
struct was designed to replace the entire lynx1 coding
sequence. Homologous recombination was detected
by Southern blot analysis (Figure 1B). As expected, the
complete loss of lynx1 protein in the lynx12/2 animals
was evident in Western blots of protein extracts from
lynx12/2 relative to wild-type+/+ and lynx1+/2 littermate
brains (Figure 1C). The lynx12/2 animals demonstrated
no gross abnormalities in size, viability, CNS morphol-
ogy, or longevity (data not shown).
Nicotine-Induced Currents in lynx1 Null Mutant Mice
Demonstrate Hypersensitivity to Agonist
Direct measurements of nicotine sensitivity were carried
out using whole-cell patch-clamp recordings of neurons
in brain slices of lynx12/2 versus wild-type mice. The
medial habenula was chosen for these experiments be-
cause of the high level of expression of nAChRs (Shef-
field et al., 2000) and the coexpression of lynx1 and
nAChRs in this region. Application of a 250 ms nicotine
pulse to neurons in the medial habenula (Figure 2B) eli-
cited larger peak responses in slices from lynx12/2 ani-
mals than those of wild-type animals (Figure 2A) for
nicotine concentrations between 1 and 20 mM. For the
entire tested nicotine concentration range (0.1 mM to
300 mM), the data reveal a decrease in the EC50 from
89.0 6 2.2 mM in wild-type mice to 9.0 6 0.7 mM in
lynx12/2 mice (Figure 2C). These currents were blocked
by the nAChR antagonist mecamylamine (mec) and re-
covered during wash out (middle traces), indicating a
specific involvement of nAChRs in this response. Anal-
ysis of the decay rate of the nicotine response revealed
that the half-maximal response times in neurons from
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compared to those of wild-type neurons, (1.4 6 0.19 s)
(Figure 2D). The peak responses are determined primar-
ily by activation processes and show clear hypersensi-
tivity, and these kinetic data also suggest that removal
of lynx1 can alter the deactivation and/or desensitization
processes of nAChRs in vivo.
lynx1 Null Mutant Neurons Display Increased
Sensitivity to Nicotine
Since some aspects of nicotinic receptor hypersensitiv-
ity may be mediated via intracellular Ca2+ levels, we
measured the effect of nicotine on Ca2+ levels in primary
cortical cultures from lynx12/2 and wild-type mice. Neu-
rons were exposed either to buffer or 10 mM nicotine.
Cultured cells were then loaded with the Ca2+-sensitive
indicator fluo-3, and fluorescence measurements were
obtained (Figure 3A). Incubation of wild-type cultures
Figure 2. Hypersensitive Nicotinic Responses in the Medial Habe-
nula of lynx1 Null Mutant Mice
Whole-cell patch-clamp recordings from neurons in wt versus lynx1
null mutant brain slices. (A) Representative recordings from a habe-
nular neuron in response to nicotine. The top traces show a response
to 20 mM nicotine, of a wt neuron (upper) and a lynx12/2 neuron
(lower), followed by its response during perfusion of 10 mM mec
and a wash out of at least 5 min. The bottom traces show the com-
mand to the piezoelectric manipulator (penultimate), which places
the pipette tip within 20 mm of the cell, and to the pressure apparatus
(bottom), which ejects a 250 ms pulse of nicotine.
(B) Micrograph of a lynx12/2 habenular neuron, with recording pi-
pette (left) and nicotine-filled application pipette (right).
(C) Average whole-cell responses from neurons in slices from wt or
lynx12/2mice in response to nicotine at concentrations ranging from
0.1 mM to 300 mM. t test, p < 0.01 at 5 mM. 0.1 mM, n = 3 (ko), 3 (wt); 1
mM, n = 3 (ko), 3 (wt); 5 mM, n = 18 (ko), 8 (wt); 20 mM, n = 5 (ko), 4 (wt);
100 mM, n = 5 (ko), 6 (wt); 300 mM, n = 2 (ko), 5 (wt). EC50 is 89.06 2.2
with a nH = 1.3 (wt) and 9.0 6 0.7 mM, nH = 1.1 (ko).
(D) Significant increase in the time to decay to 50% of the maximal
response to 5 mM nicotine. 1.40 6 0.19 s in wt (n = 8) and 2.20 6
0.22 s in lynx12/2 (n = 16) neurons. t test, p < 0.01.
Error bars show mean 6 SEM.with 10 mM nicotine did not result in a significant change
in steady-state Ca2+ levels, whereas lynx12/2 cultures
demonstrated a 2-fold increase in fluorescence (Fig-
ure 3B). These data indicate an effect of lynx1 on ligand
sensitivity and/or desensitization of nAChRs.
In order to test agonist sensitivity further, we mea-
sured acute responses to nicotine by measuring fluores-
cence levels in real time. Nicotine elicited a significant
increase in Ca2+ levels in lynx12/2 but not in wild-type
cultures (Figure 3C). Dose-response measurements in-
dicate that w1 mM nicotine is sufficient for activation
of nAChRs and elevation of Ca2+ levels in lynx12/2 cul-
tures (Figure 3D), but under our conditions, no change
in fluorescence was observed at any of the concentra-
tions tested for wild-type cultures (Figure 3D). We con-
clude that the altered response properties of nAChRs
in lynx1 mutant cells can result in elevated intracellular
Ca2+ levels, perhaps leading to changes in intracellular
signaling.
Removal of lynx1 Alters Synaptic Activity
Maintenance of intracellular Ca2+ homeostasis is critical
for neuronal excitability and synaptic activity. Given the
enhanced sensitivity of neurons from lynx1 null mutant
mice to nicotine and the elevations in Ca2+ levels ob-
served in these cells in response to nicotine, it seemed
likely that changes in synaptic NT release would be
present in lynx1 null mutant mice. Since synaptic re-
sponses are sensitive to nicotine in the hippocampus
and both lynx1 (Miwa et al., 1999) and nAChRs are pres-
ent in this brain region (Maggi et al., 2004), we tested
whether excitatory synaptic responses were altered in
lynx12/2 hippocampal slices. We conducted field po-
tential recordings of evoked CA3 to CA1 synaptic re-
sponses and measured PPF ratios, an indicator of the
probability of NT release, by applying two consecutive
stimuli at intervals ranging from 10 to 70 ms. As ex-
pected, potentiation of the second response relative to
the first response was observed at latency intervals of
30–70 ms in wild-type slices (Figure 4A), as residual
Ca2+ from the first stimulus adds to the Ca2+ influx dur-
ing the second, leading to more vesicle fusion and a po-
tentiationof NT release. In contrast, PPF ratios in lynx12/2
slices were significantly reduced relative to wild-type re-
sponses at intervals of 50–70 ms (Figures 4A and 4B).
Previous studies have suggested that a reduction in
PPF reflects an increased probability of vesicle fusion
and NT release, leading to a depletion of vesicle pools
available to respond to subsequent stimuli. These data
suggest alterations in synaptic efficacy in lynx12/2mice.
Enhanced Associative Learning
in lynx1 Null Mutant Mice
nAChR activation has been shown to be an important
component of specific aspects of learning and memory
(Picciotto et al., 1995). Therefore, a series of behavioral
tests were run on lynx1 null mutant animals to evaluate
learning and memory abilities relative to their wild-type
littermates. Mice were trained in a fear-conditioning par-
adigm, a test of associative and contextual learning. On
the training day, an unconditioned stimulus of a mild foot
shock was paired with a conditioned stimulus, an innoc-
uous tone. When mice were placed into the identical
training environment 24 hr later, lynx12/2 mice and
Neuron
590Figure 3. Elevated Ca2+ Levels in Response to Nicotine in Primary Cortical Cultures of lynx1 Null Mutant Mice
(A) Chronic treatment of 10 mM nicotine (1 hr) increased basal levels of fluorescence in lynx12/2 cultures. Wild-type cultures demonstrated no
difference in fluorescence between buffer (HBS)-treated and nicotine-treated cultures (upper panels). lynx12/2 cultures, however, demonstrated
an increase in baseline fluorescence upon nicotine treatment (lower panel, right two micrographs) as compared to HBS (lower panels, left two
micrographs). Corresponding phase contrast pictures are to the left of each fluorescence image. Scale bar, 50 mm.
(B) lynx12/2 neuronal cultures display elevated Ca2+ levels in cultures pretreated with 10 mM nicotine. Complete data collected from (A) also in-
dicated no significant difference in fluorescence levels in wt cultures treated with HBS (black) versus nicotine (white). Data represent at least 40
cells per genotype and condition. Student t test, p = 0.0007.
(C) lynx12/2 neurons show increased Ca2+ levels with acute applications of 1 mM nicotine. Images of the fluo-3-loaded cells were obtained for
50 s at 2 s intervals. 1 mM nicotine (horizontal bar) was applied for 10 s. Cultures from wt mice show no significant changes in fluorescence in
response to nicotine, whereas the lynx12/2 cultures exhibit a significant increase in intracellular Ca2+. The inset panel represents the maximal
fluorescence level obtained upon nicotine exposure for each cell as a fraction of baseline values. These studies were conducted in at least three
different cultures. Student’s t test, p = 0.038; lynx12/2, n = 18 cells; wt, n = 24 cells.
(D) Dose-response relation for intracellular Ca2+ levels in response to varying nicotine concentrations (1 mM to 1 mM, 10 s application). The
lynx12/2 cultures exhibit an increase in intracellular Ca2+ with increasing concentration of nicotine. In wt cultures, there is no change in fluores-
cence at the highest dose (1 mM nicotine). These studies were conducted in at least three cultures. lynx12/2 cultures: 1 mM, n = 32 cells; 0.1 mM,
n = 20 cells; 10 mM, n = 32 cells; and 1 mM, n = 28 cells. Wild-type cultures, n = 24 cells, mean 6 SEM.
Error bars show mean 6 SEM.wild-type littermates showed no difference in their freez-
ing response, demonstrating that lynx12/2mice are nor-
mal with respect to contextual learning (Figure 5A, left).
In cue-associated learning, the animals were placed into
a novel environment and presented with the shock-as-
sociated tone. lynx12/2mice demonstrated a significant
increase in freezing to tone as compared to their wild-
type littermates, indicating an alteration in associative
learning (Figure 5A, right). The animals did not show dif-
ferences when placed in the altered environment, prior
to the presentation of tone, indicating no difference in
unconditioned fear (data not shown). These data are
suggestive of a specific effect of lynx1 on associative
fear learning as compared to either unconditioned fear
or contextual memory.
To assess the specificity of action of lynx1 in memory
processes, lynx12/2 mice were analyzed in two other
forms of contextual conditioning: passive avoidance
conditioning and Morris water maze learning. In passive
avoidance conditioning, mice were placed in the light
chamber of a two-chambered box, and the latency to
enter into the dark, preferred chamber was measured,whereupon the mice were given a mild foot shock.
Lynx12/2 display no differences from wild-type when
the latency to enter into the dark chamber was mea-
sured the following day (Figure 5B). Mice were then as-
sessed for performance in the Morris water maze learn-
ing task. Mice were trained for 8 days to swim through
water to reach a stationary hidden platform, and the la-
tency to find the platform was measured. No significant
differences were observed between lynx12/2 and wild-
type mice (Figure 5C) in either the training phase (left)
or when the hidden platform was relocated to a different
position on the ninth day (the transfer test, upper right).
These data are consistent with the lack of effect
observed in lynx1 null mutant mice in the contextual
component of the fear-conditioning task.
These behavioral data are suggestive of a specific in-
volvement of lynx1 in cue-associated learning as op-
posed to contextual memory. Alternatively, enhanced
freezing to tone in lynx12/2 mice could be due to a
generalized increase in fear, although the lack of differ-
ence in baseline freezing or freezing to context argues
against this. To test for differences in anxiety levels,
lynx Modulation of Nicotinic Receptors In Vivo
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paradigm, a more sensitive test for anxiety. Mice were
placed for 5 min in a plus-shaped maze that consisted
of two open, white arms and two closed, black arms
and were scored for entries into the open arm, entries
into the closed arm, and time spent in the open arms.
lynx12/2 mice displayed no significant differences from
wild-type mice in any of these parameters (Figure 5D),
although lynx12/2 mice displayed a nonsignificant in-
crease in time spent in the open arm. We conclude
from these studies that lynx12/2mice manifest no differ-
ences in basal levels of anxiety. Thus, increased anxiety
is unlikely to account for the freezing to tone observed in
the fear-conditioning test.
Enhanced Behavioral Nicotine Sensitivity
in lynx1 Null Mutant Mice
Nicotine receptor activation has been shown to stimu-
late locomotor activity in both rats and mice (Clarke
and Kumar, 1983, King et al., 2004). To test whether be-
havioral responses to nicotine were altered in lynx12/2
animals, a series of locomotor tests were performed.
To measure general activity levels in lynx12/2 mice,
they were tested for diurnal locomotor activity over a
72 hr period (Figure 6A), as well as in a novel environment
Figure 4. Field Potential Recordings Were Taken in CA1 Stratum
Radiatum in Response to Paired Stimulation of CA3 Schaeffer
Collaterals
(A) Representative recordings of paired-pulse stimulation of wt (top
trace) versus lynx12/2 (ko) mouse slices (bottom trace). Synaptic
responses from wt slices demonstrate a marked enhancement of
the second pulse compared to the first (top). In contrast, synaptic re-
sponses from lynx12/2 slices showed a significant reduction of the
second pulse relative to the first (bottom). Scale bars: vertical,
5 mV; horizontal, 5 ms.
(B) Quantitation of lynx12/2 slices (white) as compared to wt (black)
mice exhibit reduced PPF ratios at intervals ranging from 30 to 70 ms
as compared to wt mice. On the x axis, the interpulse interval (i.p.i.)
from 10 to 70 ms at 10 ms increments is plotted. There was no sig-
nificant difference at intervals less than 50 ms, n = 10 slices (ko),
n = 5 slices (wt). For i.p.i. of 50 ms, p = 0.037; i.p.i. of 60 ms, p =
0.023; i.p.i. of 70 ms, p = 0.038.
Error bars show mean 6 SEM.for 20 min (Figure 6B). No differences between lynx12/2
animals and wild-type littermates were observed in
either diurnal locomotion (Figure 6A) or in response to
novelty (Figure 6B), indicating that general activity levels
were not significantly altered in lynx12/2 mice.
To test for sensitivity to nicotine, nicotine was admin-
istered to lynx12/2 animals and their wild-type litter-
mates chronically (at least 6 weeks). Motor coordination
and motor learning were assessed using an accelerating
rotarod paradigm. lynx12/2 mice given saccharin alone
in their drinking water showed no significant differences
in rotarod performance from wild-type mice, either on
the initial test day or on subsequent training days
(Figure 6C). Although wild-type mice treated with nico-
tine plus saccharin (200 mg/ml nicotine in 2% saccharin)
showed a trend toward improved performance on the
accelerating rotarod compared to saccharin-treated
wild-type mice in earlier trials, this difference was not sig-
nificant (data not shown). In contrast, nicotine-treated
lynx12/2 mice displayed a significant improvement in
rotarod performance on the second day of training
relative to similarly treated wild-type mice, demonstrat-
ing a greater effect of nicotine on motor learning in
lynx12/2mice than their wild-type littermates (Figure 6D).
The heightened responsiveness of lynx12/2 mice to nic-
otine in this motor test is consistent with the observation
that cultured neurons from lynx12/2 animals are also
more responsive to nicotine (Figure 3) and is also consis-
tent with our hypothesis that elimination of lynx1 alters
nAChRs toward heightened receptor sensitivity.
Neurons of lynx1 Null Mutant Mice Are More
Sensitive to Excitotoxic Insult
Treatment of cultured neurons with glutamate or gluta-
mate receptor agonists results in an influx of Ca2+ into
the cell that can lead to cell death (McLeod et al.,
1998). Pretreatment of neurons with nicotine prior to glu-
tamate exposure can protect cells from glutamate-medi-
ated excitotoxic cell death (Stevens et al., 2003). Since
lynx12/2 cortical neurons showed increased Ca2+ accu-
mulation upon nicotine administration, we addressed
whether lynx12/2 neurons are more vulnerable to gluta-
mate toxicity and whether nicotine remains neuroprotec-
tive in the absence of lynx1. As shown previously, wild-
type cultures exhibited a significant decrease in cell
viability upon 100 mM glutamate treatment, and 1 hr pre-
treatment of nicotine protects wild-type neurons from
cell death (Figures 7A and 7B, left panel) (Dajas-Bailador
et al., 2000). In contrast, lynx12/2 neurons were more
sensitive to glutamate-mediated excitotoxicity, and the
neuroprotective effect of nicotine was completely abol-
ished (Figures 7A and 7B, right panel). Previous studies
have shown that nicotine-mediated neuroprotection
usually occurs at low doses of nicotine, and the protec-
tive effect of nicotine is eliminated and can even result
in more cell death with higher doses of nicotine. Consis-
tent with the idea that the lynx12/2 cultures exhibit a shift
in the dose-response curve to nicotine, these data sug-
gest that the removal of lynx1 results in heightened sen-
sitivity to nicotine and that a dose of nicotine that is nor-
mally neuroprotective is excitotoxic. These data also
suggest that there may be an increased vulnerability to
neurotoxic insult in lynx12/2 mice, mediated through
elevations in Ca2+ due to nAChR hyperactivation.
Neuron
592Figure 5. Enhancement of Associative Learn-
ing Ability in lynx1Null Mutant Mice Observed
in Fear-Conditioning Assays
(A) No differences in freezing were observed
before conditioning between wt mice (black)
and lynx12/2 (ko) mice (white) (data not
shown). No differences were observed in
freezing in the training cage 24 hr later (con-
text), indicating there are no changes in con-
textual learning in lynx12/2 versus wt mice.
lynx12/2 mice demonstrate a significant in-
crease in freezing to tone as compared to wt
mice (right). This was measured as the differ-
ence in freezing before and after tone presen-
tation. p = 5.5 3 1023, n = 8 (wt), n = 12 (ko).
(B) Passive avoidance learning analyses indi-
cate no difference in performance in lynx12/2
mice versus wt mice.
(C) Morris water maze: no differences be-
tween lynx12/2 mice versus wt mice in learn-
ing to reach the hidden platform were ob-
served. Learning curves as plotted from day
1 to day 8 were the same between lynx12/2
and wt mice (left). Furthermore, there were
no differences when the platform was moved
to another location (the transfer test) or in
swim speed.
(D) Elevated plus maze test of anxiety. Mice
were placed in an elevated plus maze, with
two dark, closed arms and two light, open
arms. Mice were placed in the maze for 5 min
and scored for time spent in the light arms
and entries into the light and dark arms. No
significant differences were observed be-
tween genotypes for these parameters.
Error bars show mean6 SEM.Late-Onset Vacuolating Neurodegeneration
in lynx1 Null Mutant Mice
Given the enhanced vulnerability of cultured lynx1
null mutant neurons to excitotoxic stimuli, we werenext interested in determining whether the chronic
disturbance of nAChR activity evident in lynx12/2
animals might result in cell loss in vivo. Thus, we per-
formed an anatomic study using histological stains onFigure 6. Enhancements in Nicotine-Medi-
ated Motor Learning Performance in lynx1
Null Mutant Mice
(A) Diurnal activity measured in a home cage
environment over a 72 hr period. The number
of beam breaks was measure and averaged
across 3 days. No significant differences
were observed between wt and lynx12/2
mice.
(B) Locomotor activity in a novel environ-
ment: Animals were placed in an open field
box for a 20 min period of time, and the num-
ber of beam breaks was measured (upper).
No significant differences were observed be-
tween lynx12/2 and wt mice on the initial day
of testing (upper) or the second day (lower).
(C) lynx12/2mice demonstrate no differences
from wt in an accelerating rotoarod para-
digm, indicating no differences in motor coor-
dination or motor learning.
(D) lynx12/2 (ko) mice treated with nicotine
showed significant differences in rotarod per-
formance from untreated lynx12/2 or wt mice
on the second day of training. No differences
were observed on the initial day of testing
(data not shown). Data plotted represents
averages of trials 5–8 on day 2. p value =
5 3 1024.
Error bars show mean 6 SEM.
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593Figure 7. lynx1 Null Mutant Cortical Cultures
Exhibit Increased Excitotoxic Cell Death and
a Loss of Nicotine-Mediated Neuroprotection
Nicotine-mediated neuroprotection against
glutamate toxicity is abolished in primary cor-
tical cultures from lynx12/2 mice. Cultures
were pretreated with nicotine or buffer and
then challenged with 100 mM glutamate. (A)
Phase pictures and merged fluorescence im-
ages of calcein-AM and ethidium-stained wt
cells demonstrate a reduction in live cells
(green) and an increase in dead cells (red) in
glutamate-treated cultures. Glutamate treat-
ment reduced cell survival (56%), and nico-
tine protected neurons from glutamate-medi-
ated cell death (77%). Phase pictures and
merged images from lynx12/2 (ko) cultures
demonstrate that there is an increase in gluta-
mate-induced cell death (18%) compared to
wt. In addition, nicotine is not protective in
the absence of lynx1 (23%). (B) Quantitation
of cell death in wt and lynx12/2 (ko) cultures.
Live cells are stained green throughout the
cell body and projection. Dead cells exhibited
red staining or weak punctuated green stain-
ing. A one-way ANOVA was used to deter-
mine significance. *Glutamate versus control
(p < 0.005; LSD post hoc test). #Nicotine pre-
treatment versus glutamate alone (p < 0.005;
LSD post hoc test). **In lynx12/2 cultures,
both glutamate treatment and nicotine pre-
treatment versus glutamate treatment in wt
cultures. n = at least 200 cells/condition,
mean 6 SEM. Error bars show mean 6 SEM.lynx12/2 versus wild-type coronal brain sections. We
detected no significant difference between lynx12/2
and wild-type mouse brains at 9 months of age (data
not shown). However, inspection of brains from lynx12/2
animals taken at 12 months revealed the presence of
large vacuoles in the dorsal striatum (Figure 8A) and iso-
lated brainstem regions (data not shown). Most of these
lesions were present in the pinker, eosinic areas of the
sections, indicating that the degeneration was occurring
within axonal tracts within the striatum (Figure 8B). Fur-
ther evidence of axonal degeneration was found in the
cerebellum (Figure 9A), where nAChRs have been dem-
onstrated (Kaneko et al., 1998) and where vacuolation
was found to occur at high levels within the neuropil of
the cerebellar lobes (Figures 9A and 9B) and the superior
cerebellar peduncle (Figure 9C).
To determine whether the vacuolating phenotype of
lynx12/2 brains might be affecting neurons, we per-
formed DeOlmos amino cupric silver staining for disinte-
grative neuronal degeneration on cross-sections of
12-month-old mutant and wild-type brains. Consistent
with the vacuolation within axon-dense regions, we ob-
served a predominance of silver staining within axontracts coursing through the striatum as well as silver
labeling within the corpus callosum (Figure 8C) and in
the cerebellum (Figure 9D), demonstrating increased
neuronal degeneration within aging lynx1 mutant mouse
brains.
To assess the progressive nature of this degenerative
phenotype, we measured the number of lesions present
in the striatum of lynx1mutant mouse brains from 6 to 18
months of age (Figure 10). We quantitated the number of
vacuoles within the striatum of each mouse brain and
observed an age-dependent increase in vacuolation,
first detectable in 12-month-old lynx12/2 mice and in-
creasing at 15 and 18 months of age (Figure 10A). We
also performed quantitative analyses of the silver-
stained sections, revealing a significant increase in la-
beling of lynx12/2 as compared to wild-type brains in
the dorsal striatum (Figure 10B, left) and the medial cor-
pus callosum (Figure 10B, right). Our results are con-
sistent with previous reports that hyperactivation of
nAChRs can result in CNS damage and support the hy-
pothesis that persistent elevations in nicotinic choliner-
gic signaling make a contribution to neuronal degenera-
tion within aging lynx12/2 mouse brains.
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Is Exacerbated by Nicotine
If increased activity of nAChRs in lynx1 mutant mice is
responsible for this vacuolating phenotype, then phar-
macologic manipulations that influence the activity of
these receptors might alter the course of degeneration.
To test this idea, a solution of nicotine and saccharin,
or saccharin alone, was administered to cohorts of
lynx12/2 animals and their wild-type littermates through
their drinking water. Administration of the nicotine solu-
tion was begun at 8 months of age, before the observed
onset of degeneration, and continued for a period of 10
months. As shown in Figure 10C, there were no signifi-
cant differences in vacuolation in the striatum of saccha-
rin- versus nicotine/saccharin-treated wild-type mice
(left). However, in lynx12/2mice treated with the nicotine
solution, we observed a significant increase in vacuola-
tion (Figure 10C, right). These data strongly suggest that
the degenerative phenotype we observed in lynx12/2
brains results from increased nAChR activity, consistent
with the enhanced vulnerability of lynx12/2 neurons to
excitotoxic stimuli and the loss of neuroprotective effect
documented above (Figure 7).
Figure 8. lynx1 Null Mutant Mice Undergo Degeneration within the
Dorsal Striatum
(A) Light micrographs of H&E-stained coronal sections of wt (left)
and lynx12/2 (right) mouse brains indicate a vacuolating phenotype
in 1-year-old lynx12/2 brains. Wild-type and lynx12/2 brains were
analyzed at the same level in a cross-section of the striatum. Vacu-
olation was observed predominantly in the dorsal striatum ([A],
right). Montage ofw40 micrographs taken at 203 magnification.
(B) Individual micrograph of the striatum of H&E-stained coronal
sections, as in (A), reveals vacuolation, especially in the darker, eo-
sinic regions that label axonal tracts coursing through the striatum in
lynx2/2 (right) but not wt (left) brains. 203 magnification.
(C) DeOlmos silver cupric staining of degenerating neurons indi-
cates increased staining in lynx12/2 (right) as compared to wt brain
sections (left). Silver grain deposition is preferentially localized to
axon bundles coursing though the striatum, reaching to and from
the cerebral cortex. 203 magnification.Neurodegeneration in lynx1 Null Mutant Mice
Requires nAChRs
Our previous in vitro studies, including single-channel
recordings of nAChR activity with and without lynx1,
demonstrated a direct effect of lynx1 on nAChRs. If the
degenerative phenotype of lynx12/2 mice reflects the
loss of its ability to modulate nAChR activity, then dele-
tion of nAChRs would be expected to rescue the degen-
erative phenotype observed in lynx12/2 animals. To test
this idea, we crossed the lynx1 null mutation onto
nAChR mutant backgrounds to prepare double-mutant
animals in which the effect of nAChRs on the lynx12/2
degenerative phenotype could be assessed. As shown
in Figure 10D, a significant reduction in the number of
Figure 9. Cerebellar Degeneration Preferentially Affects Axonal
Tracts in lynx1 Null Mice
(A) Coronal brain sections of lynx12/2 (right) and wt (left) 1-year-old
mice through the cerebellum stained with H&E stain indicate a va-
cuolating degeneration in the neuropil in lynx12/2 but not wt mouse
brains. Bregma, 26.56; interaural, 22.76. Montage of H&E-stained
brain sections were imaged at 103 magnification and stitched to-
gether with Zeiss KS400 software.
(B) High-power magnification of (A) in the neuropil of the interior cer-
ebellum in wt (left) and lynx12/2 (right) mice at 203 magnification.
(C) Images of the superior cerebellar peduncle in wt (left) and
lynx12/2 (right) mouse brains. Sections at bregma 25.88, interaural
22.08 mm indicate a vacuolating degeneration in the pink, eosinic
region at the border between the cerebellum and the brainstem,
indicating a preferential loss of axons in lynx12/2 and not wt
mice. Micrographs imaged at 203 magnification.
(D) Silver staining of degenerating neurons indicates high levels of
silver stain in the cerebellum in lynx12/2 (right) but not wt (left) mouse
brains. 203 magnification.
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595Figure 10. nAChRs Are Involved in the Vacuolation Observed in
lynx1 Null Mutant Mice
(A) Vacuolation is observed in the striatum of lynx12/2 (ko) mice
(white triangles) at the age of 12 months onward as compared to
wt mice (black squares). At 6 months, n = 3 (wt), n = 3 (ko); at 9
months, n = 6 (wt), n = 6 (ko); at 12 months, n = 5 (wt), n = 10 (ko), Stu-
dent’s t test, p = 2.8 3 1026; at 15 months, n = 3 (wt), n = 3 (ko),
p = 0.037; at 18 months and older, n = 5 (wt), n = 5 (ko), p = 6 3
1025, ko values compared to wt values.
(B) Quantitative analysis of DeOlmos silver cupric staining of
lynx12/2 versus wt brains. Light micrographs were taken under
the same conditions for each brain in the dorsal midbrain. Quanti-
tation of silver grains indicated a significantly higher level of stain-
ing in lynx12/2 sections (white) versus wt sections (black) in the
dorsal striatum (left) or in the corpus callosum (right). Striatum,
p = 0.003; corpus callosum, p = 7.2 3 1026.
(C) Chronic nicotine treatment exacerbates vacuolation in lynx12/2
(ko) but not wt striata. Nicotine-treated mice (200 mg/ml in 2% sac-
charin, white) or a control solution (2% saccharin, black). Nicotine-
treated lynx12/2 mice show a significant increase in vacuolation as
compared to untreated or treated wt mice. n = 3 (ko-nic), 3 (ko+nic),
3 (wt-nic), 2 (wt+nic). Student’s t test, wt-nic versus ko+nic, p = 8.63
1023; ko+nic versus ko-nic, p = 0.009; wt-nic versus ko-nic, p = 0011.
(D) nAChRs null mutant mice provide a partial rescue of the vacuo-
lating phenotype observed in striata of lynx12/2 mice. Brains of
lynx12/2/a7 nAChR2/2 mice show an almost complete rescue of
vacuolation as compared to those of lynx12/2mice. p < 0.05 (ANOVA
LSD post hoc analysis). The striatum of lynx2/2/b2 nAChR2/2 double
mutant mice showed a reduction in vacuolation as compared to thatlesions present in the striatum at 15 months of age was
observed in both lynx12/2/b2 nAChR2/2 and lynx12/2/
a7 nAChR2/2 double mutant mice relative to their litter-
mates bearing only the lynx12/2 mutation. It is notable
that the rescue of degeneration in lynx12/2/a7
nAChR2/2 was greater than that observed lynx12/2/b2
nAChR2/2 double mutant animals, since a7 nAChRs
have a greater Ca2+ conductance than b2 nAChRs
(Berg and Conroy, 2002). These data demonstrate that
lynx1 action in vivo requires a7 and b2 nAChRs. Taken
together with the in vitro data presented previously
and in the current study and the differential effects of
nicotine treatment on motor learning and neurodegener-
ation we have observed in lynx12/2 animals (Figures 6
and 10), the rescue of the degenerative phenotype in
lynx1 mutant animals by deletion of nAChRs provides
a strong argument for a direct role of lynx1 in modulation
of nAChR activity in vivo.
Discussion
The analyses of lynx1 null mutant mice we present in this
study reveal several important new features of lynx1
function and its impact on cholinergic activity in the cen-
tral nervous system. Whole-cell recordings of responses
to nicotine pulses in brain slices show that loss of lynx1
results in hypersensitivity of nAChRs to nicotine and to
prolonged nAChR receptor activation. These changes
are sufficient to raise intracellular Ca2+ levels in lynx1
null mutant but not in wild-type neurons in response to
acute or maintained nicotine. lynx1 null mutant mice
exhibit a reduction in paired-pulse facilitation ratios in
brain slices, indicating increased synaptic efficacy
within neuronal ensembles. lynx1 mutant mice perform
better than wild-type littermates on specific tasks of
associative learning, and lynx1 mutant mice are more
responsive to nicotine in a motor-learning paradigm.
Finally, loss of lynx1 modulation leads to increased
vulnerability to excitotoxic stimuli and loss of the neuro-
protective effect of nicotine. Accordingly, aging lynx1
null mutant mice suffer from a progressive, vacuolating
degeneration of the brain that is exacerbated by nicotine
administration and rescued by null mutations in nAChRs.
The involvement of lynx1 in nAChR modulation dem-
onstrated here has important consequences for studies
of nAChR function in the brain. The properties of lynx1
action in vitro are supported by the patch-clamp studies
reported here, which demonstrate an w10-fold shift in
the dose-response relationship of nAChRs to nicotine
toward more sensitive receptors in lynx1 mutant mouse
brain slices as compared to those of wild-type mice.
Changes in nicotine sensitivity confer on the organism
marked physiological effects that correlate with the de-
gree of change in the EC50. Mutations in nAChRs induc-
ing a greater than 100-fold shift in EC50 in ooctyes cause
neuronal cell loss and neonatal death (Labarca et al.,
2001). More moderate nAChR mutations that confer
of lynx12/2 mice (p = 0.003), though to a much smaller degree than
the rescue achieved with the lynx12/2/a7 nAChR2/2 mice (p = 4.2
3 1024). n = 5 (wt), 9 (lynx12/2), 11 (lynx12/2/b2 nAChR2/2), 5
(lynx12/2/a7 nAChR2/2), 2 (b2 nAChR2/2), 2 (a7 nAChR2/2). wt ver-
sus lynx12/2 (p < 0.001).
Error bars show mean 6 SEM.
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zure susceptibility (Fonck et al., 2005; Bertrand et al.,
1998) and increased addictive propensity, but no appar-
ent neonatal loss of neurons. Our results reveal that
lynx1 removal causes a comparatively subtle gain-of-
function of wild-type nAChRs in vivo, perhaps allowing
elucidation of cholinergic processes that might other-
wise be difficult to discern in vivo. For example, the abil-
ity of lynx1 to modulate nAChR kinetics, agonist affinity,
and desensitization may help to explain the discrepancy
between dose-response curves and EC50 values of
nAChRs in vivo, where lynx1 is generally present, as
compared to results obtained using heterologous ex-
pression systems that do not include lynx1 (Quick and
Lester, 2002; Truong et al., 2001).
Although our studies cannot decisively identify the
biophysical mechanism of lynx1 action, several aspects
of our data are consistent with earlier conclusions that
lynx1 affects nAChR desensitization. First, nicotine re-
sponses in lynx1 null mutant brain slices decay back to
baseline more slowly than those in wild-type mice (Fig-
ure 2). Second, w1 hr exposure to 1 mM nicotine pro-
duces a sustained Ca2+ increase in lynx1 null mutant
but not wild-type neurons (Figure 3); thus, a regimen of
nicotine administration that desensitizes nAChRs in
wild-type mice (Vijayaraghavan et al.,1992) allows per-
sistent activation of nAChRs in lynx1 mutant cells. De-
sensitization is an overall term for a complex and incom-
pletely described series of conformational transitions
that favor bound agonist but have closed channels.
Compared with the transition to the open state, transi-
tions to desensitized states have a higher activation
energy but result in more stable states. As a result, nic-
otinic receptors enter these desensitized states in re-
sponse to maintained exposure to ACh, nicotine, or
other agonists (Lester et al., 2004, Buisson and Ber-
trand, 2001). Long-term nicotine exposure has been
shown to shift the EC50 to more sensitive receptors
and slow the onset of desensitization, through a mecha-
nism involving isomerization of nAChRs from a low to
high affinity state. Nicotinic receptor desensitization
does not directly involve changes in receptor number
(Marks et al., 1992) or expression of receptors at the
cell surface (Whiteaker et al., 1998). Desensitized states
are primarily reached from the open state, so that hyper-
sensitivity to agonists is often accompanied by hyper-
sensitivity to desensitization (for instance, see Fonck
et al., 2005). Desensitization may have the selective ad-
vantage of protecting neurons against excitoxicity due
to prolonged agonist exposure. We propose that, in ad-
dition to its direct effects on sensitivity (Figures 2A, 2C,
3C, and 3D), lynx1 also acts to change the relative stabil-
ity and/or transition energies among activated and de-
sensitized states. Thus, we propose that lynx1 acts as
an allosteric modulator of nAChR(s) to maintain low
ACh sensitivity and a good safety margin against ago-
nist overstimulation of these critical receptors.
Such shifts in agonist sensitivity and desensitization
kinetics reveal downstream consequences for removal
of nAChR modulators in Ca2+ imaging studies con-
ducted on primary neuronal cultures from lynx1 null
mutant mice. Under our conditions, only cultures from
lynx1 mutant mice display a dose-dependent increase
in intracellular Ca2+ upon nicotine treatment. Nonicotine-mediated increases in Ca2+ were observed in
wild-type cultures, supportive of hypersensitivity to nic-
otine of nAChRs in lynx1 mutant cultures. Hypersensitiv-
ity to Ca2+ increases were observed following nicotine
pulses in mice with a hyperactivating mutation of the
a4 nAChR subunit as well (Tapper et al., 2004), support-
ing the idea that nAChR activation can induce rises in
Ca2+ levels, whether via nAChR receptor channels them-
selves or through alternate means such as voltage-
dependent Ca2+ channel activity (Rathouz and Berg,
1994) or Ca2+-induced Ca2+ release from intracellular
stores (Sharma and Vijayaraghavan, 2003).
Elevations in Ca2+ levels, such as those observed in
lynx1 null mutant neurons, can have significant conse-
quences for synaptic signaling (Dittman et al., 2000).
The reduction of PPF ratios in lynx1 mutant mice is an
indicator of enhanced synaptic efficacy within neuronal
ensembles, which is thought to result from a depletion of
readily available vesicle pools in response to a large ini-
tial influx of Ca2+. This can inhibit facilitation of the sec-
ond stimulus, even under conditions of higher Ca2+ con-
centrations. nAChRs localized on presynaptic terminals
are able to regulate Ca2+ entry, and thus NT release, via
Ca2+ influx directly or by membrane depolarization.
In vivo, nicotinic currents desensitize rapidly (Wooltor-
ton et al., 2003; Marks et al., 1994). Thus, we infer that,
without the desensitizing influence of lynx1, nAChRs
can make greater contributions to elevations of Ca2+
levels, resulting in increased vesicular fusion and more
efficient synaptic signaling. This is supported by evi-
dence that conditions that favor nAChR desensitization
prevent facilitation of paired nicotine responses by the
regulation of intracellular Ca2+levels (Klein and Yakel,
2005) and with published reports of nicotine enhancing
the presynaptic release of NTs (Mansvelder et al.,
2002; McGehee et al., 1995) and synaptic efficacy in
the developing hippocampus (Maggi et al., 2004).
The increased tone-paired freezing observed in these
animals is consistent with the reduction of PPF, since
fear conditioning is correlated negatively with PPF in
wild-type mice (Shinnick-Gallagher et al., 2003). En-
hancements in cue-associated freezing observed in
lynx1mutant mice are indicative of improvement in com-
plex forms of learning and memory (Schafe et al., 2001).
We believe this to be due to an increase in learning,
rather than due to elevations in anxiety in the mutant
mice, as there were no significant differences in elevated
plus maze performance. Sensory and motor alterations
could produce freezing behavior that mimics improved
fear-conditioned memory. However, as the animals
freeze to the identical context and to the tone, but not
in the contextually altered environment on the test day,
we conclude that the alterations in sensory or motor
abilities cannot account for the increased freezing to
tone in lynx1 mutant mice (Crawley, 2000). Additionally,
the fact that lynx1mutant animals are able to learn on the
rotarod task further supports this, as the rotarod task is
dependent on visual rather than auditory cues. Our data
support a model in which lynx1 mutant mice have a
heightened sensitivity to nicotine, leading to enhanced
synaptic plasticity and increases in associative learning.
The results obtained in the rotarod test that revealed
that, in contrast to wild-type mice, motor learning in
lynx1 mutant mice is sensitive to chronic exposure to
lynx Modulation of Nicotinic Receptors In Vivo
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volvement of nAChR activation in behavior (Gould and
Wehner, 1999).
Both in vivo and in vitro studies have shown that a7
and a4/b2* nAChRs contribute to the neuroprotective
effects of nicotine in neurons. We have shown here
that primary neuronal cultures made from lynx1 mutant
mice show a greater susceptibility to the excitotoxic ef-
fects of glutamate and loss of the neuroprotective effect
of nicotine observed in wild-type neurons. While the el-
evation of Ca2+ levels observed in lynx1 mutant neurons
can have positive effects, such as improved learning
and greater capacity for synaptic alterations, elevated
Ca2+ levels are strongly correlated with susceptibility
to excitotoxic cell death. The loss of nicotine-mediated
neuroprotection in lynx1 mutant cultures is consistent
with previous in vitro studies that show that nicotine-
mediated neuroprotection is generally observed at low
doses of nicotine, whereas high concentrations of nico-
tine can exacerbate cell death. The neurotoxic effect of
chronic hyperstimulation has been demonstrated for
both the a4 and a7 nAChR subunits, where hyperactivat-
ing mutations lead to neurodegeneration. Given these
precedents, we propose that the degenerative pheno-
type observed in mice lacking lynx1 is due to the loss
of lynx1 modulation of nAChRs. Chronic nAChR-depen-
dent elevations in intracellular Ca2+ levels contribute to
the probability that Ca2+ influx as a result of normal activ-
ity will exceed the Ca2+-buffering capacities of the cell,
leading to neuronal vulnerability. Thus, the probability
that a neuron will exceed the threshold for excitotoxic
death (Clarke and Lumsden, 2005) is increased in lynx1
mutant animals, resulting in a progressive degenerative
phenotype that is significant, although not as severe as
that seen with hypersensitive mutations of nAChRs.
The greater ability of a7 nAChR as compared to b2
nAChR null mutant mice to rescue neurodegeneration
in lynx1 mutant mice is consistent with this idea, since
a7 nAChRs are more permeable to Ca2+ than b2 nAChRs
(Fucile, 2004; Berg and Conroy, 2002). However, since
intracellular Ca2+ may rise through alternative means,
the vacuolation in lynx1 null mutant mice may not de-
pend solely of the relative extent of Ca2+ flux through
specific nAChR subunits. For example, it has been pos-
tulated that a7* nAChRs are responsible for Ca2+ influx
through its channels, whereas b2* subunit-containing
nAChRs depolarize the membrane and thereby activate
voltage-gated Ca2+ channels that allow Ca2+ entry (Tsu-
neki et al., 2000). We propose that the desensitizing in-
fluence of lynx1 on nAChRs provides a high safety mar-
gin for exposure to ACh or nicotine by causing a shift
toward less sensitivity to ACh and more rapid desensiti-
zation, thus reducing the available pool of receptors that
can be activated by successive stimuli. Our data sug-
gest that one of the major roles of lynx1 within the
CNS is to buffer the cell from destructive excitotoxic
events that must occur during the normal lifetime of
the animal.
This study indicates that lynx1 acts as a modulatory
component on nAChR receptors to maintain receptor
activity within a narrowly defined window that is benefi-
cial for neuronal function. A molecule acting in such a ca-
pacity can have important neurological consequences.
For instance, in the human epilepsy disorder ADNFLE,alterations in desensitization kinetics and gating char-
acteristics of nAChRs can shift the balance between
excitation and inhibition too far toward excitation. The
C. elegans mutant odr2, a related family member to
lynx1, causes olfactory deficits (Chou et al., 2001), and
mutations in the secreted lynx1 homolog SLURP-1
cause changes in agonist affinity of nAChRs, which re-
sult in an inflammatory disorder of the skin, Mal de Me-
leda (Chimienti et al., 2003). It seems highly probable
that other members of the lynx1 gene family, and indeed
other prototoxin-like molecules, also function as modu-
latory components of other CNS receptors to maintain
activity within this narrowly defined window. Given the
vital function of lynx1 in modulating nicotinic tone and
fine-tuning the activity of neuronal ensembles demon-
strated in this study, we believe lynx1 will be an impor-
tant component in many aspects of cholinergic function,
both in the CNS and in the periphery where lynx1 ex-
pression has been demonstrated (Sekhon et al., 2005).
The effect of lynx1 on the kinetic properties of nAChRs
has important therapeutic implications. lynx1 provides
a novel target for drug discovery that could be of value
for identifying compounds to treat cognitive loss in ag-
ing or as a consequence of dementia. This strategy pres-
ents advantages to current treatments for neurological
disorders such as Alzheimer’s disease or Parkinson’s
disease that seek to enhance cholinergic activity by inhi-
bition of acetylcholinesterase (Trinh et al., 2003) or in-
creases in agonist concentration (Kelton et al., 2000;
Chorvat et al., 1998), since increases in agonist binding
can lead to downregulation of nAChR function by desen-
sitization. Targeting allosteric modulators of nAChR
could circumvent such problems by increasing signaling
of nAChRs without triggering desensitization or com-
pensatory downregulation (Hurst et al., 2005; Pereira,
et al., 2002; Maelicke et al., 2000). Drugs that act on
lynx1 modulators could allow access to circuits within
the brain that previously have been intractable through
direct targeting of cholinergic receptors. Our data point
to lynx1 as a promising new target for pharmacologic
manipulation of nAChR function in vivo, while providing
a cautionary note that the benefits of pharmacologic in-
hibition of lynx1 must be weighed against the degener-
ative effects of chronic nAChR activation.
Experimental Procedures
Targeting Mutagenesis and Detection
Gene-specific primers were used to amplify an frt-neo-recA plasmid
using a bacterial recombination method described in Yu et al. (2000).
Standard methods were used for gene targeting (see the Supple-
mental Data). Ssp1-digested genomic DNA probed with a 30 external
probe recognized a 12 kb band (wt) and a 9 kb recombinant band.
Western analysis utilized purified anti-lynx pAb to probe extracts
from lynx12/2, lynx1+/2, and lynx1+/+ forebrain.
Patch-Clamp Electrophysiology in Medial Habenula
See Supplemental Data and Tapper et al. (2004). Internal pipette so-
lution, in mM: 100 mM K+ gluconate, 0.1 CaCl2+, 1.1 EGTA, 5 MgCl2+,
10 HEPES, 3 ATP, 3 phosphocreatine, 0.3 GTP, pH to 7.2 with KOH.
Somatic whole-cell recordings were made from visually identified
habenular neurons from P14–P17 mice. For nicotine application,
a glass pipette connected to a relay-controlled pressure device
was moved to within 20 mm of the recorded cell using a piezoelectric
manipulator, and nicotine was applied for 250 ms and retracted.
10 mM mecamylamine was bath perfused.
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Mixed cortical cultures (11–13 days old) were made from E16–E18
fetal mice as has been described (Stevens et al., 2003); see the Sup-
plemental Data. After nicotine or HBS pretreatment for 1 hr, cells
were loaded with 2 mM fluo-3 for 10 min RT. Images were obtained
using a 203 objective on a Nikon TE300 inverted microscope equip-
ped with a cooled CCD camera (Hamamatsu orca), collected at 2 s
intervals and adjusted for the level of background intensity, digitally
colored and analyzed using IPLab software, measuring somatic
pixel density, adjusted against background, for over 40 neurons
per genotype/condition.
For acute nicotine experiments, Ca2+ influx was determined as the
change from basal fluorescence upon a 10 s application of 1 mM nic-
otine ([stimulated level 2 basal level]/basal level of fluorescence),
quantitated as described by Vijayaraghavan et al. (1992). lynx12/2,
n = 18; wt, n = 24. Dose-response measurement: extracellular Ca2+
was increased to 3 mM and 0 mM MgCl2+ to increase the changes
observed in Ca2+ influx at lower doses. Nicotine doses ranged
from 1 mM to 1 3 1026 mM. The wt cultures showed no significant
change with 1 mM nicotine (DF/F = 0.04, n = 24 cells), so lower doses
of nicotine were not tested. These experiments were conducted in
three different cultures. 1 mM, n = 32 cells; 0.1 mM, n = 20 cells;
10 mM, n = 32 cells; 1 mM, n = 28 cells.
Hippocampal Slice Electrophysiology
CA3 to CA1 field potentials were recorded in P28–P35 transverse
hippocampal slices in response to monopolar stimulation of 50%–
60% maximum response. Two stimuli were applied with a minimum
interval delay ranging from 10 ms to a maximum delay of 70 ms. For
details, see the Supplemental Data.
Behavioral Tests
Fear Conditioning
Mice were presented with two pairings of the tone with foot shock
(0.5 mA, 2 s). For contextual conditioning, freezing was scored for
5 min in the conditioning chamber. For the cued test, mice were
placed into a different cage, and a novel odor (orange extract) was
added to the context. Mice were scored for freezing in the altered
context for 3 min before and 3 min during presentation of the tone
(cued conditioning test). For details, see the Supplemental Data.
Passive avoidance learning and Morris water maze learning, see
the Supplemental Data. Rotarod: lynx12/2 and wt mice were admin-
istered either 2% saccharin or 200 mg/ml of nicotine hemisulfate salt
in 2% saccharin through their drinking water. Adult mice were tested
in squads of four, for eight trials per day on consecutive days. Ani-
mals were tested with an accelerating paradigm of a 1 RPM starting
speed and a rate of acceleration of 0.1 RPM/s. Animals were scored
for time to fall or time to stop running.
Assessment of Neurotoxicity
Nicotine (10 mM) or buffer preincubation was carried out for 1 hr at
37C, and 100 mM glutamate or buffer treatment was assessed after
18–20 hr. Cells were treated with 0.16 mM calcein-AM-0.36 mM
ethidium homodimer in HBS 2.1 (40 min, RT). Live cells were stained
green throughout the soma and projections, whereas dead cells had
red staining only in the nucleus or highly punctate green staining.
Neurotoxicity was calculated as percentage survival [live cells/
(live + dead cells)] relative to control cells. Four to six coverslips
were examined per treatment, and a total of 10 to 15 randomly se-
lected fields (103) were captured using IPLab software. At least
200 cells were counted per condition, and each experiment was re-
peated in at least two different cultures.
Histology
Micrographs of H&E-stained coronal sections were taken with a
Zeiss Axioplan2 microscope with a 103 objective, and the individ-
ual pictures were stitched together to create a montage. For details,
see the Supplemental Data. For quantitation of the vacuolation, sec-
tions were picked at the same rostral-caudal level through the stria-
tum. Bregman 0.00, interaural 3.80 mm. The number of gaps in the
neuropil of at least a cell body in diameter were counted to yield
the number of vacuoles per striatal hemisphere. For nicotine-treat-
ment, drinking water contained 200 mg/ml nicotine in 2% saccharin,
starting at 8 months for a 10 month period of time. a7 and b2nAChR2/2 mice were obtained from the Beaudet laboratory and
bred to C57Bl6/J6 lynx1+/2 mice. Fifteen-month-old mouse brains
were drop-fixed in 4% paraformaldehyde in PB. Wild-type, n = 5;
b2 nAChR2/2/lynx12/2, n = 6; a7 nAChR2/2/lynx12/2, n = 5; a7
nAChR2/2, n = 2; b2 nAChR2/2, n = 2. Silver staining of degenerating
neurons was conducted by a modification of DeOlmos amino cupric
silver stain (Neurosciences Associates, Knoxville, TN). Density mea-
sures (NIH Image) of 203 dorsal striatal micrographs were normal-
ized against the wt.
Supplemental Data
The Supplemental Data for this article can be found online at http://
www.neuron.org/cgi/content/full/51/5/587/DC1/.
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